Radient Pharmaceuticals Corporation fka RXPC

[Top Penny]

RXPC ~ 40% of people who should be tested aren't getting tested for colorectal cancer. In my opinion Onko-Sure (DR-70) has definable strengths lacking with CEA. CEA has definable strengths lacking with Onko-Sure, both have their pros and cons. With caner awareness and concern on the rise especially colorectal cancer, efficient testing methods are dire. Cancer is big business. Speculating on some sort of deal is not a pipe dream imo.